Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selenium in chronic liver disease.

P J Thuluvath1, D R Triger

  • 1Department of Medicine, University of Sheffield Medical School, United Kingdom.

Journal of Hepatology
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes.

The American journal of gastroenterology·2017
Same author

A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1.

Journal of viral hepatitis·2014
Same author

Liver transplantation in the United States, 1999-2008.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Endoscopic retrograde cholangiopancreatography, but not esophagogastroduodenoscopy or colonoscopy, significantly increases portal venous pressure: direct portal pressure measurements through endoscopic ultrasound-guided cannulation.

Endoscopy·2008
Same author

Endoscopic ultrasound and fine needle aspiration for the diagnosis of hepatocellular carcinoma.

Minerva gastroenterologica e dietologica·2008
Same author

Effect modification in liver allografts with prolonged cold ischemic time.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same journal

Optimising the screening strategy for early-stage hepatocellular carcinoma.

Journal of hepatology·2026
Same journal

Corrigendum to: "A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse" [J Hepatol (2014) 60: 782-91].

Journal of hepatology·2026
Same journal

Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort.

Journal of hepatology·2026
Same journal

Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial.

Journal of hepatology·2026
Same journal

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same journal

Reply to "Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy".

Journal of hepatology·2026
See all related articles

This study found that selenium (Se) levels are significantly lower in patients with chronic liver disease, regardless of the cause. Low selenium is linked to poor nutritional status, not reduced dietary intake, highlighting its importance in liver health.

Area of Science:

  • Biochemistry
  • Clinical Nutrition
  • Hepatology

Background:

  • Selenium (Se) is an essential trace element with antioxidant properties.
  • Chronic liver diseases, including alcoholic liver disease (ALD) and non-alcoholic liver disease (NALD), are associated with various metabolic derangements.
  • The role of selenium in the pathogenesis and progression of liver disease requires further elucidation.

Purpose of the Study:

  • To investigate the status of selenium in patients with different types of chronic liver disease.
  • To correlate selenium levels with nutritional status and liver biochemistry.
  • To determine the relationship between selenium levels and dietary intake in liver disease.

Main Methods:

  • Measurement of serum, urinary, and hepatic selenium levels in patients with ALD, NALD, and controls.

Related Experiment Videos

  • Assessment of nutritional status through anthropometric measurements and serum albumin.
  • Evaluation of dietary selenium intake in a subset of patients.

    • Main Results:

    • Serum and hepatic selenium levels were significantly lower in patients with both ALD and NALD compared to healthy and disease controls.
    • Urinary selenium excretion was comparable across all groups.
    • Serum selenium showed a strong positive correlation with serum albumin and anthropometric measurements in liver disease patients.

    Conclusions:

    • Selenium levels are diminished in chronic liver disease irrespective of etiology.
    • Reduced selenium status in liver disease is likely associated with compromised nutritional status rather than inadequate dietary intake.
    • Maintaining adequate selenium levels may be crucial for managing patients with chronic liver conditions.